Young Guy, Albisetti Manuela, Bonduel Mariana, Brandao Leonardo, Chan Anthony, Friedrichs Frauke, Goldenberg Neil A, Grabowski Eric, Heller Christine, Journeycake Janna, Kenet Gili, Krümpel Anne, Kurnik Karin, Lubetsky Aaron, Male Christoph, Manco-Johnson Marilyn, Mathew Prasad, Monagle Paul, van Ommen Heleen, Simioni Paolo, Svirin Pavel, Tormene Daniela, Nowak-Göttl Ulrike
Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Circulation. 2008 Sep 23;118(13):1373-82. doi: 10.1161/CIRCULATIONAHA.108.789008. Epub 2008 Sep 8.
The aim of the present study was to estimate the impact of inherited thrombophilia (IT) on the risk of venous thromboembolism (VTE) onset and recurrence in children by a meta-analysis of published observational studies.
A systematic search of electronic databases (Medline, EMBASE, OVID, Web of Science, The Cochrane Library) for studies published from 1970 to 2007 was conducted using key words in combination as both MeSH terms and text words. Citations were independently screened by 2 authors, and those meeting the inclusion criteria defined a priori were retained. Data on year of publication, study design, country of origin, number of patients/controls, ethnicity, VTE type, and frequency of recurrence were abstracted. Heterogeneity across studies was evaluated, and summary odds ratios and 95% CIs were calculated with both fixed-effects and random-effects models. Thirty-five of 50 studies met inclusion criteria. No significant heterogeneity was discerned across studies. Although >70% of patients had at least 1 clinical risk factor for VTE, a statistically significant association with VTE onset was demonstrated for each IT trait evaluated (and for combined IT traits), with summary odds ratios ranging from 2.63 (95% CI, 1.61 to 4.29) for the factor II variant to 9.44 (95% CI, 3.34 to 26.66) for antithrombin deficiency. Furthermore, a significant association with recurrent VTE was found for all IT traits except the factor V variant and elevated lipoprotein(a).
The present meta-analysis indicates that detection of IT is clinically meaningful in children with, or at risk for, VTE and underscores the importance of pediatric thrombophilia screening programs.
本研究旨在通过对已发表的观察性研究进行荟萃分析,评估遗传性血栓形成倾向(IT)对儿童静脉血栓栓塞症(VTE)发病及复发风险的影响。
使用医学主题词(MeSH)和文本词相结合的关键词,对1970年至2007年发表在电子数据库(Medline、EMBASE、OVID、Web of Science、Cochrane图书馆)中的研究进行系统检索。由2名作者独立筛选文献,并保留符合预先设定纳入标准的文献。提取发表年份、研究设计、原产国、患者/对照数量、种族、VTE类型及复发频率等数据。评估研究间的异质性,并采用固定效应模型和随机效应模型计算汇总比值比及95%可信区间(CI)。50项研究中有35项符合纳入标准。未发现研究间存在显著异质性。尽管超过70%的患者至少有1项VTE临床危险因素,但对于所评估的每种IT特征(及合并的IT特征),均显示与VTE发病存在统计学显著关联,汇总比值比范围从因子II变异的2.63(95%CI,1.61至4.29)到抗凝血酶缺乏的9.44(95%CI,3.34至26.66)。此外,除因子V变异和脂蛋白(a)升高外,所有IT特征均与复发性VTE存在显著关联。
本荟萃分析表明,在患有VTE或有VTE风险的儿童中检测IT具有临床意义,并强调了儿科血栓形成倾向筛查项目的重要性。